Skip to content

Prognosis and Course of COVID-19 Infection in Hospitalised Patients

Prognosis and Course of COVID-19 Infection in Hospitalised Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04752085
Enrollment
345
Registered
2021-02-12
Start date
2020-11-01
Completion date
2023-01-10
Last updated
2023-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19, SARS-CoV Infection

Keywords

COVID-19, chitotriosidase, SARS-CoV Infection

Brief summary

The aim of the cohort prospective observational study is to define the major factors influencing the course of COVID-19 infections and its prognosis in hospitalised patients. The investigators plan to include 300 patients hospitalised with COVID-19 infection. The phone contacts with patients are due after 90 and 180 days after discharge.

Interventions

DIAGNOSTIC_TESTChitotriosidase activity

The chitotriosidase activity will be measured in all the subjects

Sponsors

I.M. Sechenov First Moscow State Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Hospitalisation with COVID-19

Exclusion criteria

* History of hospitalisation with COVID-19 infection * Discharge from the hospital before the end of the treatment course * Transfer to another hospital

Design outcomes

Primary

MeasureTime frameDescription
Need in biological therapy or/and respiratory supportUp to 1 monthThe primary endpoint is the need in biological therapy or/and respiratory support including noninvasive ventilation during hospital stay

Secondary

MeasureTime frameDescription
Number of days spent in hospitalUp to 1 monthThe investigators plan to assess the overall length of hospitalisation due to COVID-19 infection as an outcome measure
All-cause death90 daysTo assess the all-cause death 90 days after discharge

Countries

Russia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026